V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002396 | 250008326 | 1.69 | 71 | Palliative (P) | 2020-12-10 | 2020-12-21 | Atezolizumab | 02 | Y | ATEZOLIZUMAB | 100619159 |
| 250002398 | 250008327 | 0 | 61.9 | null | 2018-12-29 | 2019-01-13 | AVELUMAB + AXITINIB | 02 | N | AVELUMAB | 100268931 |
| 250002407 | 250008331 | 1.94 | 66.7 | Curative (C) | 2021-11-14 | 2022-03-13 | null | 02 | N | DOCETAXEL | 100650076 |
| 250002410 | 250008332 | 1.66 | 102 | Curative (C) | 2019-12-16 | 2020-01-23 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | CETUXIMAB + CISPLATIN + FLUOROURACIL | 101773111 |
| 250002413 | 250008334 | 1.67 | 82.9 | Palliative (P) | 2021-05-28 | 2021-07-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | CARBOPLATIN + FLUOROURACIL | 100158875 |
| 250002414 | 250008335 | 1.7 | 89.9 | Palliative (P) | 2020-02-05 | 2020-02-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100241738 |
| 250002416 | 250008336 | 1.69 | 71.25 | Palliative (P) | 2018-11-22 | 2018-11-22 | CETUXIMAB | 02 | Y | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 101053374 |
| 250002430 | 250008337 | null | null | Palliative (P) | null | 2019-09-29 | Epirubicin (weekly) | null | N | CAPECITABINE + IRINOTECAN | 100584231 |
| 250002434 | 250008338 | 1.64 | 50.4 | Curative (C) | 2019-10-02 | 2019-10-16 | null | 02 | null | TRIAL UNSPECIFIED | 101792055 |
| 250002460 | 250008341 | 1.59 | 69.5 | Curative (C) | null | 2021-08-25 | Sunitinib | N | N | IMATINIB | 100235580 |
| 250002466 | 250008342 | null | null | null | null | 2019-03-13 | PACLITAXEL | null | null | TIVOZANIB | 100932428 |
| 250002468 | 250008343 | 1.61 | null | Palliative (P) | 2021-02-03 | 2021-07-12 | VIDE | 02 | N | ATEZOLIZUMAB | 100463497 |
| 250002493 | 250008346 | 1.52 | 59 | null | 2019-09-19 | 2019-11-15 | null | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100390503 |
| 250002495 | 250008347 | null | null | null | null | 2020-04-09 | AFATINIB | null | null | CARBOPLATIN + ETOPOSIDE | 101263192 |
| 250002496 | 250008348 | 1.82 | 0 | null | 2021-06-08 | 2021-07-09 | Trial Unspecified | 02 | N | CARBOPLATIN | 101022174 |
| 250002499 | 250008350 | 1.66 | 59.6 | Palliative (P) | 2019-01-03 | 2019-01-03 | Mitomycin Intravesical | 02 | N | CARBOPLATIN + PACLITAXEL | 101290057 |
| 250002502 | 250008351 | 1.59 | 59.3 | null | 2020-02-02 | 2020-02-14 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | POUT TRIAL | 100633098 |
| 250002509 | 250008355 | null | null | null | null | 2020-01-16 | STS Rhabdomyosarcoma RMS 2005 IVA | null | N | DOCETAXEL | 100413560 |
| 250002512 | 250008356 | 0 | 59 | Adjuvant (A) | 2019-09-10 | 2019-09-16 | Etoposide IV | null | null | BUSULFAN + MELPHALAN | 101653937 |
| 250002515 | 250008357 | 1.59 | 77 | Palliative (P) | 2019-02-18 | 2019-03-19 | Tivozanib | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101254913 |
| 250002519 | 250008358 | 1.78 | 59.3 | null | 2022-05-08 | 2022-05-20 | null | 01 | null | SPIRE TRIAL | 100586466 |
| 250002522 | 250008359 | 1.82 | 71.3 | null | 2021-07-11 | 2021-11-05 | null | 02 | null | TRIAL UNSPECIFIED | 101018822 |
| 250002525 | 250008360 | null | null | Curative (C) | null | 2021-05-09 | Cisplatin + Pemetrexed | 02 | N | TRABECTEDIN | 100606801 |
| 250002529 | 250008361 | null | null | Palliative (P) | null | 2019-10-31 | Oxaliplatin + Modified de Gramont | null | N | ATEZOLIZUMAB | 100323076 |
| 250002531 | 250008362 | 1.55 | 57.6 | Palliative (P) | 2022-05-20 | 2022-05-22 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN + ETOPOSIDE | 100477388 |
| 250002537 | 250008364 | 1.67 | 80.75 | Palliative (P) | 2019-06-19 | 2019-06-24 | Atezolizumab | 02 | null | CETUXIMAB | 100221084 |
| 250002543 | 250008366 | 1.74 | 59.6 | Palliative (P) | 2017-02-05 | 2017-02-13 | Paclitaxel Priming | 02 | null | PAZOPANIB | 100880144 |
| 250000084 | 250008367 | 1.74 | 62.2 | Palliative (P) | 2018-08-07 | 2018-08-07 | null | N | N | EW EUROEWING 2012 ARM B IE | 100334374 |
| 250000331 | 250008370 | null | null | null | null | 2019-05-30 | IPM | 02 | null | PANITUMUMAB | 101320011 |
| 250000648 | 250008371 | 1.74 | 0 | Curative (C) | 2018-07-04 | 2018-07-05 | Rucaparib | 01 | N | IPILIMUMAB + NIVOLUMAB | 100068845 |
| 250000718 | 250008372 | 1 | 59.2 | Palliative (P) | 2019-10-06 | 2019-10-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CARBOPLATIN | 100876386 |
| 250000752 | 250008374 | 0 | 83.3 | Palliative (P) | 2020-02-24 | 2020-03-24 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100655978 |
| 250000919 | 250008379 | 1.71 | 61.6 | Curative (C) | null | 2020-03-16 | PACLITAXEL | Y | null | CISPLATIN + FLUOROURACIL | 101233838 |
| 250000920 | 250008380 | 1.77 | 68.9 | null | null | 2018-09-12 | VINORELBINE | null | N | DOXORUBICIN | 100989360 |
| 250001052 | 250008382 | 1.8 | 72.2 | Palliative (P) | 2021-03-08 | 2021-03-08 | null | 02 | null | NIRAPARIB | 101706684 |
| 250001060 | 250008384 | null | 74.1 | Palliative (P) | 2019-09-26 | 2019-11-25 | null | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100462361 |
| 250001074 | 250008385 | 1.7 | 85.9 | null | 2017-09-19 | 2017-11-20 | Cisplatin + Pemetrexed | 02 | Y | CARBOPLATIN + FLUOROURACIL | 100864065 |
| 250001092 | 250008386 | 1.83 | 10.2 | Palliative (P) | 2020-03-22 | 2020-04-01 | IVADo | 02 | N | CARBOPLATIN + PACLITAXEL | 100809939 |
| 250001131 | 250008388 | 1.52 | 81.5 | null | 2019-07-17 | 2020-02-18 | TEMOZOLOMIDE | 02 | N | GEMCITABINE | 100206432 |
| 250001134 | 250008389 | 1.84 | 66.7 | Palliative (P) | 2018-11-05 | 2018-11-05 | null | 02 | null | NB HRNBL-1 ISOTRETINOIN | 100538026 |
| 250001208 | 250008390 | 1.71 | 16.3 | Palliative (P) | 2019-10-10 | 2019-10-26 | CARBOPLATIN + FLUOROURACIL | 02 | Y | DOXORUBICIN + IFOSFAMIDE | 101544258 |
| 250001319 | 250008391 | 1.64 | 43.3 | Palliative (P) | 2021-09-15 | 2021-10-29 | NB BEACON Temozolomide alone | 02 | null | CARBOPLATIN + ETOPOSIDE | 101740740 |
| 250001331 | 250008392 | 1.76 | 11.6 | Palliative (P) | null | 2022-01-02 | null | null | null | DOCETAXEL | 100604720 |
| 250001358 | 250008393 | 1.32 | 99.4 | null | null | 2019-09-19 | Carboplatin + Liposomal Doxorubicin | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100992873 |
| 250001605 | 250008394 | 1.62 | 109 | null | 2020-04-06 | 2020-04-12 | CARBO + FLUOROURACIL | 02 | N | ENZALUTAMIDE | 101745907 |
| 250001607 | 250008395 | null | null | null | null | 2022-03-29 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100796180 |
| 250001677 | 250008397 | 1.68 | 68.38 | Palliative (P) | 2020-03-23 | 2020-03-23 | PACLITAXEL | 02 | N | CARBOPLATIN + ETOPOSIDE | 100034115 |
| 250001692 | 250008398 | 1.65 | 23.5 | Palliative (P) | null | 2021-05-12 | Imatinib 400mg | 02 | N | CAPECITABINE + OXALIPLATIN | 100928227 |
| 250001697 | 250008399 | 1.72 | 67.85 | null | 2019-09-30 | 2020-02-05 | EW Rel rEECur Ifosfamide | 02 | null | GEMCITABINE | 101840571 |
| 250001761 | 250008400 | 1.65 | null | null | null | 2018-07-04 | null | null | null | SUNITINIB | 100399430 |